Healthcare IT News February 19, 2025
The virtual care organization said the Drug Enforcement Administration’s draft framework would impose on clinical decision-making. It also flagged compliance impracticalities around provider exclusions and arbitrary requirements.
The U.S. Drug Enforcement Agency’s proposed rule to establish special registrations for providers and telemedicine platforms to prescribe certain schedules of controlled substances without requiring an in-person doctor’s visit requires “meaningful” clarification and adjustments, according to the American Telemedicine Association and ATA Action.
If key provisions to ensure “workability and effectiveness” are not addressed, “significant gaps will remain, leaving too many patients without access to necessary care,” ATA said in the Feb. 14 comment letter signed by Kyle Zebley, ATA senior vice president of public policy and executive director of ATA Action.
...Today's Sponsors
Today's Sponsor